Long COVID prevalence and risk factors in adults residing in middle- and high-income countries: secondary analysis of the multinational Anti-Coronavirus Therapies (ACT) trials by John Eikelboom, Lucas Etienne Hermans, Sean Wasserman, Lizhen Xu

Get full text

Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants. by Luciane Cruz Lopes, Frederick A Spencer, Ignacio Neumann, Matthew Ventresca, Shanil Ebrahim, Qi Zhou, Neera Bhatnagar, Sam Schulman, John Eikelboom, Gordon Guyatt

Get full text

Comparison of total event analysis and first event analysis in relation to heterogeneity in cardiovascular trials by Shun-Fu Lee, Chinthanie Ramasundarahettige, Hertzel C. Gerstein, William F. McIntyre, John Eikelboom, Martin J. O’Donnell, Yueci Zhou, Shrikant I. Bangdiwala, Lehana Thabane

Get full text

2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome by Jack Wei Chieh Tan, Derek P Chew, David Brieger, John Eikelboom, Gilles Montalescot, Junya Ako, Byeong-Keuk Kim, David KL Quek, Sarah J Aitken, Clara K Chow, Sok Chour, Hung Fat Tse, Upendra Kaul, Isman Firdaus, Takashi Kubo, Boon Wah Liew, Tze Tec Chong, Kenny YK Sin, Hung-I Yeh, Wacin Buddhari, Narathip Chunhamaneewat, Faisal Hasan, Keith AA Fox, Quang Ngoc Nguyen, Sidney TH Lo

Get full text